When initial therapy proves insufficient, treatment escalation includes: Biologic DMARDs targeting specific inflammatory pathways (TNF inhibitors, IL-6 inhibitors, T-cell costimulation blockers, B-cell depleting agents) Targeted synthetic DMARDs such as JAK inhibitors (tofacitinib, baricitinib, upadacitinib), which carry FDA boxed warnings for serious cardiovascular events, malignancy, and thrombosis [24] [25] Combination DMARD therapy Short-term glucocorticoids for symptom control during treatment initiation Before starting biologic or targeted synthetic DMARDs, screening for tuberculosis and hepatitis B is recommended, along with appropriate vaccinations according to ACR guidelines
Larazotide supports the integrity of your gut lining and may help reduce symptoms of leaky gut, especially for those with gluten sensitivity or autoimmunity
Clean Insides: Some pathogens can impair your digestion and immune function
They are convenient, cost-effective, and offer a consistent source of this essential vitamin
This mechanistic complementarity means combining the peptides addresses more healing pathway simultaneously than either alone